Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||
GSE240505 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [RNA-seq]
|
|
|
22 | Hongjian Jin | Mar 04, 2024 | ||
GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
|
26 |
|
Hongjian Jin | Mar 02, 2024 | |
GSE240980 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
|
8 | Hongjian Jin | Jun 26, 2024 | |||
GSE251918 |
Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations [RNA-seq]
|
|
|
8 | Hongjian Jin | Jun 05, 2025 | ||
GSE251920 |
Eradicating neuroblastomas by an RBM39 degrader in combination with anti-GD2 immunotherapy regardless of cancer cell state alterations
|
|
|
18 |
|
Hongjian Jin | Jun 05, 2025 | |
GSE253185 |
Credentialling a c-MYC-driven genetic neuroblastoma model
|
|
5 |
|
Hongjian Jin | Nov 05, 2024 | ||
GSE255205 |
Credentialling a c-MYC-driven genetic neuroblastoma model [RNAseq-NB]
|
|
14 | Hongjian Jin | Nov 05, 2024 |